Major pharmaceutical firm reports breakthrough in universal influenza vaccine trial
A pharmaceutical firm's universal influenza vaccine breakthrough signals potential structural shifts in public health strategy, vaccine markets, and pandemic preparedness—raising both transformative opportunities and systemic risks.